{{Rsnum
|rsid=2069514
|Chromosome=15
|position=74745879
|Orientation=plus
|GMAF=0.1873
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}[[rs2069514]], also known as -3860G>A, is a SNP in the [[CYP1A2]] gene.

The [[rs2069514]](A) allele defines the CYP1A2*1C variant.

{{PharmGKB
|RSID=rs2069514
|Name_s=CYP1A2:(-)3860G>A; CYP1A2*1C; CYP1A2:(-)2964G>A
|Gene_s=CYP1A2
|Feature=
|Evidence=PubMed ID:16188490; PubMed ID:16495781; PubMed ID:17164366
|Annotation=Risk among nonsmokers for gastric adenocarcinoma, increased risk for hepatocellular carcinoma.
|Drugs=
|Drug Classes=
|Diseases=
|Curation Level=Curated
|PharmGKB Accession ID=PA161145043
}}

{{PMID Auto
|PMID=22141270
|Title=[Single nucleotide polymorphisms of CYP1A2 and their correlation with prostate cancer]
}}
{{PMID Auto
|PMID=16864595
|Title=The influence of genetic polymorphisms in Ahr, CYP1A1, CYP1A2, CYP1B1, GST M1, GST T1 and UGT1A1 on urine 1-hydroxypyrene glucuronide concentrations in healthy subjects from Rio Grande do Sul, Brazil.
}}

{{PMID Auto
|PMID=18936436
|Title=Prevalence in the United States of selected candidate gene variants: Third National Health and Nutrition Examination Survey, 1991-1994.
|OA=1
}}

{{GET Evidence
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs2069514
|overall_frequency_n=23
|overall_frequency_d=128
|overall_frequency=0.179688
|n_genomes=17
|n_genomes_annotated=0
|n_haplomes=21
|n_articles=0
|n_articles_annotated=0
|in_pharmgkb=Y
|autoscore=1
|webscore=N
}}

{{PMID Auto
|PMID=23128882
|Title=Role of CYP1A2 polymorphisms in breast cancer risk in women
}}

{{PMID Auto
|PMID=23462460
|Title=Current evidence on the relationship between three polymorphisms in the CYP1A2 gene and the risk of cancer.
}}

{{PMID Auto
|PMID=25081684
|Title=Four Polymorphisms in the Cytochrome P450 1A2 (CYP1A2) Gene and Lung Cancer Risk: a Meta-analysis
}}
{{on chip | 23andMe v3}}